US equities
|
NVDA
$240.38
▲+0.62%
SPCX
$172.52
▲+0.84%
MU
$1,058.92
▼-0.47%
MRVL
$286.70
▲+5.70%
AMD
$654.58
▲+3.61%
INTC
$114.54
▼-1.42%
AVGO
$378.56
▲+4.43%
TSLA
$380.11
▲+0.36%
NVDA
$240.38
▲+0.62%
SPCX
$172.52
▲+0.84%
MU
$1,058.92
▼-0.47%
MRVL
$286.70
▲+5.70%
AMD
$654.58
▲+3.61%
INTC
$114.54
▼-1.42%
AVGO
$378.56
▲+4.43%
TSLA
$380.11
▲+0.36%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Articles published by Phillips Medisize
Phillips Medisize to Present Evidence-Based Framework for High-Dose Subcutaneous Drug Delivery at the 2026 Parenteral Drug Association (PDA) Universe of Pre-Filled Syringes and Injection Devices Conference
Today 9:00 EDT
From
Phillips Medisize
Via
Business Wire
Phillips Medisize to Present Strategies for Scaling Complex In Vitro Diagnostic (IVD) Builds Through Structured CDMO Collaboration at ADLM 2026
July 23, 2026
From
Phillips Medisize
Via
Business Wire
Phillips Medisize to Showcase Advances in Inhalation and Dry Powder Inhaler Innovations at Respiratory Drug Delivery (RDD) 2026
May 07, 2026
From
Phillips Medisize
Via
Business Wire
Phillips Medisize Highlights Inhaled Drug Delivery Device Platforms and Scientific Insights at DDL 2025
December 09, 2025
From
Phillips Medisize
Via
Business Wire
Phillips Medisize Launches TheraVolt Medical Connectors to Support Next-Gen Device Integration, Connectivity and Performance
June 09, 2025
From
Phillips Medisize
Via
Business Wire
Phillips Medisize Announces Scientific Presentations and Engagements at Respiratory Drug Delivery Conference, Highlighting Its Expanded Inhalation Drug Delivery Capabilities
May 06, 2025
From
Phillips Medisize
Via
Business Wire